High Times

The best flower that landed on Brett’s desk this month was so impressive that he decided to put it straight in the freezer.

And that says something about how cannabis is being appreciated now. A great cut can be experienced in completely different ways, but sometimes the flower itself is still the part worth remembering.

The Best Flower I Got This Month Is Going Into the Freezer Without Being Smoked | High Times A Guava Tart from Purple City Genetics, grown by Most Wanted, arrived covered in trichomes and went straight into the freezer to be washed. The Cal Ripkin came as three separate products from three different operations. Two jars stayed jars. And Mark Greyshock of Greenshock Farms explains the thirty...

For years, the stereotype was simple: teenagers smoke w**d, older people don't. The latest U.S. data is flipping that picture. Teen past-month use fell from 23.1% in 2011 to 12.9% in 2025, while use among adults 65+ has been climbing.

Teen use is falling. Senior use is rising. And the American cannabis consumer is starting to look very different.

The Generational Flip: Are Teens Ditching W**d While Seniors Are Using More? What the Latest US Data Shows | High Times Cannabis use among U.S. teens has fallen to record lows even as legalization has expanded, while use among adults 65 and older is moving in the opposite direction. New federal data and recent research suggest America’s cannabis demographics may be shifting in ways that challenge long-standing assu...

Australia may be getting the world's first prescription C*D pain tablet. There's just one detail: the company's own trial didn't show it outperforming a placebo.

The eight-week study involved 155 adults, and the company says about 10% were strong responders. Now the tablet is headed to regulators anyway, raising a bigger question about what “medical cannabis” looks like when the plant becomes a pill.

This Company Wants to Sell the 'World's First' C*D Pain Tablet. Its Own Trial Didn't Beat a Placebo. | High Times An Australian company has filed for approval of a THC-free C*D tablet it calls a world first for chronic pain. Its chief executive told 7News the trial didn't outperform placebo.

The case that just blocked Trump's press ban started with High Times' founder and a pie. -- In 1970, Tom Forçade pied a federal commissioner. The government later denied him a White House press pass. He sued.

56 years later, his case is precedent:

The Case That Just Blocked Trump’s Press Ban Started With High Times’ Founder and a Pie | High Times Before he founded High Times, Tom Forçade threw a cheese pie at a member of the Commission on Obscenity and Po*******hy. The Secret Service cited the incident to deny him a White House press pass, and the case he brought with Nation correspondent Robert Sherrill, filed as Forcade v. Knight, became ...

Ed Rosenthal has been around cannabis long enough to watch an underground culture become a legal industry. His first grow book came out in the early 1970s, he helped build High Times, and in 2002 he was arrested after Oakland had deputized him to grow cannabis for medical patients.

Now, 50 years into the story, he's thinking about landrace genetics, consumption lounges, and what cannabis should actually be measuring.👇

Ed Rosenthal Looks Back on 50 Years of Cannabis on the Good PizzZa Podcast | High Times The grower, author and longtime High Times columnist sat down for episode 200 of the Good PizzZa podcast and walked through his 2002 federal case, his work preserving landrace genetics in India, the disappearance of true skunk and what he thinks cannabis contests should be measuring.

There are two Steven Froelichs in this book. One spent a decade traveling through Central America looking for co***ne, friends and fun. The other got clean, moved to London, and eventually sat down to reconstruct those years.

What makes Guatemala: High Life, Low Life interesting is that the sober Froelich refuses to judge the person he used to be. He doesn't redeem him. He just remembers him.

High Life, Low Life: Steven Froelich’s Cocaine-Fueled Journey Through Guatemala Steven Froelich spent a decade chasing cheap co***ne abroad, then wrote it down sober. On memory, the people he met, and why he refuses to repent.

What happens when you regulate the supply instead of just tolerating the sale?

The Netherlands' cannabis pilot is offering an early glimpse. Product variety has expanded, flower has gotten cheaper, and the legal supply chain is becoming more traceable. But consumers aren't suddenly using cannabis more often, and the illicit market hasn't disappeared either.

Cheaper Flower, More Choice, No Surge in Use: The Netherlands’ Cannabis Pilot Delivers Its First Results | High Times The Netherlands’ regulated cannabis experiment is already reshaping coffeeshop shelves, expanding product variety and driving down flower prices. But early findings show little change in consumption, health outcomes, or public safety—and the illicit market hasn’t disappeared.

$15.31 in Washington. $51.63 in Kentucky. Same plant, legal markets, completely different price.

The difference isn't just taxes or climate. Cannabis is still trapped inside state-by-state systems, meaning states have to build entire supply chains of their own. Until those borders open, patients and consumers are paying for the fragmentation.

Why Cannabis Prices Vary by State: $15 in Washington, $52 in Kentucky | High Times An eighth costs $15 in Washington and $52 in Kentucky, where every buyer is a patient. Former Massachusetts cannabis regulator Shawn Collins uses High Times' price index and a bourbon thought experiment to explain why state borders force every legal market to rebuild an entire supply chain, what lic...

Your doctor doesn't have to be a cannabis expert. But “I don't know” shouldn't be the end of the conversation. Gaps in cannabis training, legal uncertainty, and stigma can all make doctors hesitant to discuss medical cannabis, even when patients are asking about it.

The better conversation starts with five questions 👇

How to Talk to Your Doctor About Medical Cannabis: 5 Questions to Ask | High Times Many patients find their doctors go quiet when medical cannabis comes up. Dr. Joseph Rosado explains why, from gaps in medical training to legal caution and lingering stigma, what the evidence actually supports, and the five questions that can turn a doctor's silence into an informed conversation ab...